Related Party Transactions - Additional Information (Details)				1 Months Ended	3 Months Ended
	May 15, 2023 USD ($)	Mar. 30, 2023 USD ($) $ / shares shares	Jan. 31, 2022 USD ($) $ / shares shares	Nov. 30, 2017 TargetAntigen	Mar. 31, 2023 USD ($) $ / shares shares	Mar. 31, 2022 USD ($)	Dec. 31, 2022 $ / shares shares
Related Party Transaction [Line Items]
Rent expense incurred under operating lease					$ 45,144	$ 43,500
Number of target antigens against which antibodies are to be identified and selected | TargetAntigen				2
Revenue					$ 550,000
Gross proceeds from issuance of common stock						3,519,000
Common stock, shares issued | shares					54,857,221		49,881,613
Issuance of Common Shares					$ 2,040,000	13,230,000
Common stock, par value | $ / shares					$ 0.0001		$ 0.0001
Stock Purchase Agreement | FCMI Parent Co. | Subsequent Event
Related Party Transaction [Line Items]
Issuance of Common Shares	$ 2,960,000
January 2022 Private Placement
Related Party Transaction [Line Items]
Sale of stock, transaction date			Jan. 31, 2022
January 2022 Private Placement | FCMI Parent Co.
Related Party Transaction [Line Items]
Common stock, shares issued | shares			1,801,801
January 2022 Private Placement | Friedberg Global-Macro Hedge Fund Ltd.
Related Party Transaction [Line Items]
Common stock, shares issued | shares			1,801,801
January 2022 Private Placement | FCMI Parent Co. and Friedberg Global-Macro Hedge Fund Ltd.
Related Party Transaction [Line Items]
Gross proceeds from issuance of common stock			$ 3,999,998
January 2022 Private Placement | Dr. Maurice Zauderer
Related Party Transaction [Line Items]
Gross proceeds from issuance of common stock			$ 1,999,999
Common stock, shares issued | shares			1,801,801
January 2022 Private Placement | Board of Directors
Related Party Transaction [Line Items]
Gross proceeds from issuance of common stock			$ 100,000
Common stock, shares issued | shares			90,090
March 2023 Private Placement
Related Party Transaction [Line Items]
Sale of stock, transaction date		Mar. 30, 2023
Common Stock
Related Party Transaction [Line Items]
Issuance of Common Shares						$ 1,000
Common Stock | January 2022 Private Placement
Related Party Transaction [Line Items]
Aggregate number of shares issued and sell | shares			8,747,744
Shares issued, price per share | $ / shares			$ 1.11
Gross proceeds from issuance of common stock			$ 9,700,000
Common Stock | March 2023 Private Placement
Related Party Transaction [Line Items]
Aggregate number of shares issued and sell | shares		4,975,608
Shares issued, price per share | $ / shares		$ 0.41
Gross proceeds from issuance of common stock		$ 2,040,000.00
Surface Oncology, Inc.
Related Party Transaction [Line Items]
Number of target antigens against which antibodies are to be identified and selected | TargetAntigen				2
Revenue					$ 500,000